Bendamustine, Rituximab and Acalabrutinib in Waldenstrom's Macroglobulinemia
Bendamustine, Rituximab and Acalabrutinib in Waldenstrom's Macroglobulinemia
Active, not recruiting · NCT04624906 · Registry updated 2026-09-03Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Bendamustine, Rituximab and Acalabrutinib in Waldenstrom's Macroglobulinemia | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, Waldenstrom macroglobulinemia, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Active, not recruiting | Phase 2 | 2026-09-03 | NCT04624906 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| AstraZeneca | 806 |
| Sunnybrook Health Sciences Centre | 193 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| CHU de Quebec - University Laval | Laval | Canada | 1 |
| Cross Cancer Institute | Edmonton | Canada | 7 |
| Hamilton Health Sciences Centre - Juravinksi | Hamilton | Canada | 1 |
| McGill University Health Centre | Montreal | Canada | 27 |
| QEII Health Sciences Centre | Halifax | Canada | 4 |
| Sunnybrook Health Sciences Centre | Toronto | Canada | 167 |
| The Ottawa Hospital | Ottawa | Canada | 27 |
| Tom Baker Cancer Centre | Calgary | Canada | 5 |
| Vancouver General Hospital | Vancouver | Canada | 19 |